Benchmark Holdings PLC (LSE:BMK) - Share price


Stock Report

Benchmark Holdings PLC BMK

Last Price
GBX42.50

Day Change
1.50|3.66%

As of 11/08/2022
17:15:00 BST | GBX
Minimum 15 Minutes Delay.

Last Close41.00p
Day Range40.00 - 44.40
Mkt Cap288.60Mil
52-Wk Range39.00 - 65.90
Yield %-
ISINGB00BGHPT808
Volume11,848
P/E-
P/S0.02
P/CF0.49

Share Price

Total Returns 11/08/2022

 Chg (%)  
More ...
Benchmark Holdings PLC3.66 
FTSE 100 TR GBP-0.19
 
Financials
201920202021
More ...
Income Statement
Turnover124.01105.57125.06
Operating Profit-45.43-8.91-4.29
Net Profit-59.12-22.78-11.58
Reported EPS-10.74-3.80-1.93
Balance Sheet
Current Assets106.82145.75124.03
Non Current Assets380.59343.29357.96
Total Assets503.38489.04481.99
Current Liabilities52.2155.3863.52
Total Liabilities192.92193.60202.39
Total Equity310.47295.44279.60
Cash Flow
Operating Cash Flow-4.96-1.9710.38
Net Change in Cash-8.5556.45-31.97
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
23/05/2022PurchaseMr. Trond Williksen50.2050,00025,100.00
19/05/2022PurchaseMr. Yngve Myhre44.509,4694,214.00
18/05/2022PurchaseMr. Yngve Myhre44.5066,93229,785.00
01/12/2021PurchaseMr. Peter Lutz George62.0060,00037,200.00

Company Profile

Benchmark Holdings PLC is engaged in the healthcare sector in the United Kingdom. Its operating segment includes Genetics; Advanced Nutrition; Health; All other segments and Corporate. The company generates maximum revenue from the Advanced Nutrition segment. The Advanced Nutrition segment manufactures and provides technically advanced nutrition and health products to the global aquaculture industry. Geographically, it derives a majority of revenue from the Rest of the World and also has a presence in Norway; the Faroe Islands; Ecuador; India; Greece; Singapore; Chile, and the Rest of Europe.

Sector

Drug Manufacturers - Specialty & Generic

Index

FTSE AIM UK 50 , FTSE AIM 100 , FTSE AIM All-Share

Next Event 25/08/2022

Third Quarter Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-0.29
Op Mrgn-0.03
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive Director, Senior Independent DirectorMs. Susan Jane Searle
Non-Executive DirectorMr. Kevin Quinn
Non-Executive Director, ChairmanMr. Peter Lutz George
Non-Executive DirectorMr. Yngve Myhre
Non-Executive DirectorMr. Kristian Eikre
Executive Director, Chief Financial OfficerMs. Septima Maguire
Executive Director, Chief Executive OfficerMr. Trond Williksen
Non-Executive DirectorMr. Atle Sveinung Eide
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2022 Morningstar. All rights reserved.